209 related articles for article (PubMed ID: 22743651)
1. β-Adrenergic receptor expression in vascular tumors.
Chisholm KM; Chang KW; Truong MT; Kwok S; West RB; Heerema-McKenney AE
Mod Pathol; 2012 Nov; 25(11):1446-51. PubMed ID: 22743651
[TBL] [Abstract][Full Text] [Related]
2. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy.
Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C
J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372
[TBL] [Abstract][Full Text] [Related]
4. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
[TBL] [Abstract][Full Text] [Related]
6. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.
Li P; Guo Z; Gao Y; Pan W
Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592
[TBL] [Abstract][Full Text] [Related]
7. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
9. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma.
Debelenko LV; Perez-Atayde AR; Mulliken JB; Liang MG; Archibald TH; Kozakewich HP
Mod Pathol; 2005 Nov; 18(11):1454-60. PubMed ID: 15920541
[TBL] [Abstract][Full Text] [Related]
10. Infantile hemangiomas β
Bassi A; Filippeschi C; Oranges T; Caporalini C; Pini A; Nardini P; Gentile RM; Filippi L
Pediatr Res; 2022 Jan; 91(1):163-170. PubMed ID: 33654276
[TBL] [Abstract][Full Text] [Related]
11. A series of vascular tumors and tumorlike lesions of the bladder.
Tavora F; Montgomery E; Epstein JI
Am J Surg Pathol; 2008 Aug; 32(8):1213-9. PubMed ID: 18580491
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of WT-1 cytoplasmic stain in variety of vascular lesions.
Galfione SK; Ro JY; Ayala AG; Ge Y
Int J Clin Exp Pathol; 2014; 7(5):2536-43. PubMed ID: 24966966
[TBL] [Abstract][Full Text] [Related]
13. Biomolecular markers and involution of hemangiomas.
Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
[TBL] [Abstract][Full Text] [Related]
14. Expression of β1 adrenergic receptor in vascular anomalies in children.
Stănciulescu MC; Popoiu MC; Cîmpean AM; David VL; Heredea R; Cerbu S; Boia ES
J Int Med Res; 2021 Sep; 49(9):3000605211047713. PubMed ID: 34590496
[TBL] [Abstract][Full Text] [Related]
15. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
16. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.
North PE; Waner M; Mizeracki A; Mihm MC
Hum Pathol; 2000 Jan; 31(1):11-22. PubMed ID: 10665907
[TBL] [Abstract][Full Text] [Related]
17. Primary Vascular Tumors of Bone: A Monoinstitutional Morphologic and Molecular Analysis of 427 Cases With Emphasis on Epithelioid Variants.
Righi A; Sbaraglia M; Gambarotti M; Gibertoni D; Rovira MP; Benini S; Errani C; Brenca M; Maestro R; Dei Tos AP
Am J Surg Pathol; 2020 Sep; 44(9):1192-1203. PubMed ID: 32271190
[TBL] [Abstract][Full Text] [Related]
18. [The expression and significance of beta2-AR and VEGFR-2 in infantile hemangioma].
Xu G; Niu J; Lyu R; Zhou S; Huo R
Zhonghua Zheng Xing Wai Ke Za Zhi; 2014 Jul; 30(4):274-8. PubMed ID: 25322575
[TBL] [Abstract][Full Text] [Related]
19. Splenic vascular tumors: a histologic, immunophenotypic, and virologic study.
Arber DA; Strickler JG; Chen YY; Weiss LM
Am J Surg Pathol; 1997 Jul; 21(7):827-35. PubMed ID: 9236839
[TBL] [Abstract][Full Text] [Related]
20. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
Filippi L; Dal Monte M; Casini G; Daniotti M; Sereni F; Bagnoli P
Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
